SARS-CoV-2
Identification of a low pathogenicity clade of SARS-CoV-2
9
Proposed drug interventions for SARS CoV 2 infection
7
The Frequency of G614 SARS-CoV-2 Variant in India
7
The Conceptual Framework for SARS-CoV-2 Related Lymphopenia
9
Model of trigger mechanisms of SARS CoV-2 infections
7
SARS-CoV-2 virion stabilization by Zn binding
8
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter semiSWEET
28
Running Title: Microevolution of SARS-CoV-2 Key words: SARS-CoV-2, COVID-19, genome-wide mutations,
24
An overview of SARS‐CoV‐2 and animal infection
17
Collective Clustering Dynamics of SARS-COV-2 Particles
6
Risk of Human-to-Wildlife Transmission of SARS-CoV-2
16
Virtual Screening and Molecular Dynamics Study on Blockage of Key Drug Targets as Treatment for COVID-19 caused by SARS-CoV-2
19
SARS-CoV-2, COVID 19 Useful information
12
Structural Similarity Analysis of Spike Proteins of SARS-CoV-2 and Other SARS-related Coronaviruses
19
Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19
9
Genomic characterization and phylogenetic analysis of SARS-CoV-2 in Asia
11
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
34
CRISPR-Based Assays for Rapid Detection of SARS-CoV-2
10
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
17
Anosmia and Ageusia as Initial or Unique Symptoms after SARS-COV-2 Virus Infection (Review article)
25